NCT00803608

Brief Summary

To assess the efficacy of TrueContour® Insoles versus the current standard of care insoles in recurrence of plantar MTH ulcers in men and women, 18 years of age or older at the time of consent with clinical diagnosis of Diabetes Mellitus type 1 or type 2 who have had at least one recently healed plantar MTH foot ulcer (\>1 week but \<12 weeks since heeling) and have Loss of Protective Sensation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Feb 2009

Longer than P75 for phase_2

Geographic Reach
1 country

11 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 4, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 5, 2008

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2009

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

August 13, 2014

Status Verified

August 1, 2014

Enrollment Period

4.8 years

First QC Date

December 4, 2008

Last Update Submit

August 12, 2014

Conditions

Keywords

PlantarUlcerDiabetes

Outcome Measures

Primary Outcomes (1)

  • The first occurrence of a plantar ulcer or pre-ulcer in subjects who have had one previously healed plantar ulcer

    every 3 months

Study Arms (2)

02

ACTIVE COMPARATOR

Current standard of care insole

Device: Current standard of care insole

01

EXPERIMENTAL

TrueContour® insole

Device: TrueContour® Insole

Interventions

Novel designed insole

01

Current Medicare approved A5513 insole

02

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men and women, 18 years of age or older at the time of consent;
  • Clinical diagnosis of Diabetes Mellitus ;
  • At least one recently healed plantar MTH-related foot ulcer (\>1 week but 4 months since heeling), based on medical records or if these cannot be obtained to the subject's best recollection OR current or recurring hemorrhage into callus under at least one MTH in a patient with a prior MTH related plantar ulcer that has been documented in the medical record;
  • Barefoot plantar pressure in the area of the previous MTH-related ulcer or at the area of current hemorrhagic callus \>450 kPa;
  • Loss of Protective Sensation (refer to Section 7.2.6);
  • Community ambulator defined as having the ability or potential for ambulation outside in the community including the ability to traverse low-level environmental barriers such as curbs, stairs, or uneven surfaces, or better by subject report;
  • Ability to give consent;
  • In the opinion of the site PI the subject is willing and able to comply with the scheduled visits, treatment plan, and other trial procedures for the duration of the study.

You may not qualify if:

  • Presence of a current ulcer (see Section 7.1.1) below the malleoli, in the opinion of the site PI;
  • Partial foot amputation greater than of two metatarsal heads or rays per foot; toe amputations with the metatarsal heads left in place are permissible; complete foot amputation on one side (i.e. ambulation with a prosthesis) is permissible;
  • Charcot process that is active in the opinion of the site PI (requires immobilization beyond use of footwear that would be available through the study);
  • A prior ulcer on the plantar aspect of the heel within the last year, to the subject's best recollection that in the opinion of the site PI has high probability of recurring in the study footwear;
  • A prior ulcer on the weightbearing aspect of any toe within the last year, to the subject's best recollection that in the opinion of the site PI has high probability of recurring in the study footwear;
  • A prior ulcer on the plantar aspect of the foot associated with a mid-foot prominence at any time in the past, to the subject's best recollection that in the opinion of the site PI has high probability of recurring in the study footwear;
  • A prior ulcer on the plantar aspect of the foot associated with a mid-foot prominence at any time in the past, if the associated plantar pressure is \>450kPa
  • Barefoot plantar pressure in the mid-foot that exceeds forefoot peak plantar pressure;
  • Need for an ankle-foot orthoses in the opinion of the site PI or another provider;
  • Need for more complex intervention, i.e. the site PI's decision is that the study footwear would not be adequate for the subject's needs, e.g. a rigid outsole or custom molded shoes are deemed necessary.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (11)

Carl T Hayden VA Medical Center

Phoenix, Arizona, 85012, United States

Location

Southern Arizona Limb Salvage Alliance

Tucson, Arizona, 85711, United States

Location

Center for Clinical Research, Inc

Castro Valley, California, 94546, United States

Location

Innovative Medical Technologies

Los Angeles, California, 90024, United States

Location

Diabetic Foot and Wound Center

Denver, Colorado, 80220, United States

Location

Weil Foot & Ankle Institute

Des Plaines, Illinois, 60016, United States

Location

Hines VA Hospital

Hines, Illinois, 60141, United States

Location

Cleveland Clinic Foundation

Cleveland, Ohio, 44193, United States

Location

Blair Medical Associates, Inc

Altoona, Pennsylvania, 16602, United States

Location

Temple University School of Podiatric Medicine

Philadelphia, Pennsylvania, 19107, United States

Location

Complete Family Footcare

McAllen, Texas, 78501, United States

Location

Related Publications (1)

  • Ulbrecht JS, Hurley T, Mauger DT, Cavanagh PR. Prevention of recurrent foot ulcers with plantar pressure-based in-shoe orthoses: the CareFUL prevention multicenter randomized controlled trial. Diabetes Care. 2014 Jul;37(7):1982-9. doi: 10.2337/dc13-2956. Epub 2014 Apr 23.

MeSH Terms

Conditions

Foot UlcerDiabetes MellitusUlcer

Condition Hierarchy (Ancestors)

Foot DiseasesSkin DiseasesSkin and Connective Tissue DiseasesLeg UlcerSkin UlcerGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Joseph L Loomis, MS

    DIApedia, LLC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 4, 2008

First Posted

December 5, 2008

Study Start

February 1, 2009

Primary Completion

December 1, 2013

Study Completion

December 1, 2013

Last Updated

August 13, 2014

Record last verified: 2014-08

Locations